The DOI matches its Crossref record; 34 of the 37 references it cites were found in a registry or an index.
All progestins are not created equal
Abstract
A variety of progestins are available for therapeutic use. It is convenient to classify them into those related in chemical structure to progesterone or testosterone. Progestins related to progesterone can be subdivided into pregnanes and 19-norpregnanes, whereas those related to testosterone can be subdivided into those with and without a 17-ethinyl group. 17-Ethinylated progestins consist of the families of norethindrone (estranes) and levonorgestrel (13-ethylgonanes). Progestins administered orally undergo extensive hepatic first pass metabolism primarily by reduction and conjugation, and in most instances, relatively high progestin doses are required for therapeutic use. There are limited reliable data on the pharmacokinetics of most progestins. Some progestins are prodrugs, requiring transformation prior to exhibiting progestational activity. Qualitative and quantitative tests utilizing either human or animal species have been used to establish progestin potency. However, profound differences in progestational activity are often observed between human and animal tissues. Also, there is a misconception about androgenicity of progestins due largely to extrapolation of data from rat studies to the human. Progestins differ widely in their chemical structures, structure-function relationships, metabolism, pharmacokinetics, and potencies; they are not created equal.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Progestogens are primarily metabolized by the liver largely to form pregnanediols and pregnanolones [336,337].”
From Human steroid biosynthesis, metabolism and excretion are differentially reflected by serum and urine steroid metabolomes: a comprehensive review (2019) · cites this paper as [337]
Citations
Cites
Reproductive Endocrinology: Physiology, Pathophysiology and Clinical Management.
(1986) · Annals of Internal Medicine · doi:10.7326/0003-4819-105-3-484_1 · Cited by 413
Drospirenone: pharmacology and pharmacokinetics of a unique progestogen
Krattenmacher, R. (2000) · Contraception · doi:10.1016/s0010-7824(00)00133-5 · Cited by 375
Treatment of the Postmenopausal Woman
Løbo, R. A., Taylor, A. E., & Schlechte, J. (1995) · The Endocrinologist · doi:10.1097/00019616-199501000-00012 · Cited by 194
Simon, J. A., Robinson, D. E., Andrews, M. C., Hildebrand, J. R., Rocci, M. L., Blake, R. E., & Hodgen, G. D. (1993) · Fertility and Sterility · doi:10.1016/s0015-0282(16)56031-2 · Cited by 151
Assessment of the potency of orally administered progestins in women
King, R. J. B., & Whitehead, M. I. (1986) · Fertility and Sterility · doi:10.1016/s0015-0282(16)49880-8 · Cited by 127
Metabolism of levonorgestrel, norethindrone, and structurally related contraceptive steroids
Stanczyk, F. Z., & Roy, S. (1990) · Contraception · doi:10.1016/0010-7824(90)90093-b · Cited by 122
Phillips, A., Demarest, K. T., Hahn, D. W., Wong, F. A., & McGuire, J. L. (1990) · Contraception · doi:10.1016/0010-7824(90)90039-x · Cited by 119
Effect of low-dose oral contraceptives on androgenic markers and acne
Thorneycroft, I. H., Stanczyk, F. Z., Bradshaw, K. D., Ballagh, S. A., Nichols, M. D. N., & Weber, M. E. (1999) · Contraception · doi:10.1016/s0010-7824(99)00093-1 · Cited by 112
Pharmacokinetics and Potency of Progestins used for Hormone Replacement Therapy and Contraception
Stanczyk, F. Z. (2002) · Reviews in Endocrine and Metabolic Disorders · doi:10.1023/a:1020072325818 · Cited by 108
Kuhnz, W., Heuner, A., Humpel, M., Seifert, W., & Michaelis, K. (1997) · Contraception · doi:10.1016/s0010-7824(97)00174-1 · Cited by 106
Research works printed but not linked: 5
- Stanczyk, 1989, Pharmacokinetics of progestogens, Int. Proc. J., 1, 11
- Stanczyk, 1996, Introduction: structure–function relationships, metabolism, pharmacokinetics and potency of progestins, Drugs Today, 32, 1
- Kuhnz, 1993, Systemic availability of levonorgestrel after single oral administration of a norgestimate-containing oral contraceptive to 12 women, Contraception, 47, 283
- Oettel, 1995, A 19-norprogestin without a 17α-ethinyl group. I. Dienogest from a pharmacokinetic point of view, Drugs Today, 31, 499
- Teichman AT. Levonorgestrel, vol. 43. Stuart-George Thieme Verlag; 1990.
Cited by
Sorted by citations
Items 101–200 of 226
Sech, L. A., & Mishell, D. R. (2015) · Women s Health · doi:10.2217/whe.15.82 · Cited by 26
Contraception in autoimmune diseases
Benagiano, G., Benagiano, M., Bianchi, P., D’Elios, M. M., & Brosens, I. A. (2019) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1016/j.bpobgyn.2019.05.003 · Cited by 26
Novel genotoxicity assays identify norethindrone to activate p53 and phosphorylate H2AX
Gallmeier, E., Winter, J. M., Cunningham, S. C., Kahn, S. R., & Kern, S. E. (2005) · Carcinogenesis · doi:10.1093/carcin/bgi132 · Cited by 26
Oral Contraceptive Use Impairs Muscle Gains in Young Women
Riechman, S. E., & Lee, C. W. (2021) · The Journal of Strength and Conditioning Research · doi:10.1519/jsc.0000000000004059 · Cited by 25
“However, highly androgenic progestin, such as levonorgestrel and norethindrone acetate, is also found to be antiandrogenic at the same time, suppressing the action of free testosterone (39,41).”
BackgroundBenakanakere, I., Besch-Williford, C. L., Carroll, C. E., & Hyder, S. M. (2010) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-10-0064 · Cited by 25
Establishment of procedures for studying mPR-interacting agents and physiological roles of mPR
Tokumoto, T., Hossain, M. B., & Wang, J. (2016) · Steroids · doi:10.1016/j.steroids.2016.02.015 · Cited by 25
Corrigan, M. E., Drouillard, J. S., Spire, M. F., Mosier, D. A., Minton, J. E., Higgins, J. J., Loe, E. R., Depenbusch, B. E., & Fox, J. T. (2007) · Journal of Animal Science · doi:10.2527/jas.2006-396 · Cited by 24
“Differences in the structure, potency, pharmacokinetics, and metabolism of progestins have been reviewed (Stanczyk, 2003).”
BackgroundHermsmeyer, R. K., Mishra, R. G., Pavčnik, D., Uchida, B. T., Axthelm, M. K., Stanczyk, F. Z., Burry, K. A., Illingworth, D. R., Kaski, J. C., & Nordt, F. J. (2004) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000126372.14332.70 · Cited by 24
Molecular screening of Chinese medicinal plants for progestogenic and anti-progestogenic activity
Ahmed, H., Yeh, J., Tang, Y.-C., Cheng, W. T.-K., & Ou, B. (2014) · Journal of Biosciences · doi:10.1007/s12038-014-9434-z · Cited by 23
“4, Taiwan Boulevard, Xitun District, Taichung City 40704, Taiwan 2Department of Biotechnology, Asia University, 500, Lioufeng Rd., Wufeng, Taichung 41354, Taiwan *Corresponding author (Fax, +886-4-23590385; Email, brou@thu.edu.tw) Estrogen and progestins have adverse effects, and many of these adverse effects are caus…”
BackgroundInfluentialCasto, K. V., Jordan, T. R., & Petersen, N. (2022) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2022.101036 · Cited by 24
“Progestins are enzymatically converted to a variety of different metabolites of differential affinity to steroid hormone receptors (Bick et al., 2021; Stanczyk, 2003; Stanczyk et al., 2013).”
Hormonal contraception and breast cancer
Westhoff, C. L., & Pike, M. C. (2018) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2018.03.032 · Cited by 21
Liu, S., Su, H., Li, H., Liu, J.-J., Lin, L., Xu, X., Zuo, L., & Zhao, J. (2019) · Environmental Science & Technology · doi:10.1021/acs.est.9b02891 · Cited by 21
László, C., Montoya, J. P., Shamseddin, M., Martino, F. D., Béguin, A., Nellen, R., Bruce, S. J., Moniatte, M., Henry, H., & Brisken, C. (2019) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2019.07.004 · Cited by 21
Jin, Y., Duan, L., Chen, M., Penning, T. M., & Kloosterboer, H. J. (2012) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2011.12.002 · Cited by 18
“In contrast, NOR is rapidly metabolized, suggesting that NOR metabolites are responsible for its biological effects [1, 4].”
BackgroundA New Strategy for Selective Targeting of Progesterone Receptor With Passive Antagonists
Khan, J. A., Tikad, A., Fay, M., Hamzé, A., Fagart, J., Chabbert‐Buffet, N., Méduri, G., Amazit, L., Brion, J., Alami, M., et al. (2013) · Molecular Endocrinology · doi:10.1210/me.2012-1328 · Cited by 20
Advances in neurosteroids: role in clinical practice
Pluchino, N., Santoro, A. N., Casarosa, E., Wenger, J. M., Genazzani, A. D., Petignat, P., & Genazzani, A. R. (2013) · Climacteric · doi:10.3109/13697137.2013.809647 · Cited by 20
Pharmacodynamics of combined estrogen-progestin oral contraceptives: Effects on metabolism
Bastianelli, C., Farris, M., Rosato, E., Brosens, I., & Benagiano, G. (2016) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2017.1271708 · Cited by 50
What if the Women’s Health Initiative had used transdermal estradiol and oral progesterone instead?
Simon, J. A. (2014) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0000000000000169 · Cited by 19
Rible, R. D., Taylor, D., Wilson, M. L., Stanczyk, F. Z., & Mishell, D. R. (2008) · Contraception · doi:10.1016/j.contraception.2008.10.005 · Cited by 19
Hasirci, A. S., Maldonado‐Devincci, A. M., Beattie, M. C., O’Buckley, T. K., & Morrow, A. L. (2017) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.13300 · Cited by 19
“Besides, 3a,5a-THP is known to readily cross the blood–brain barrier (Zhu et al., 2001) and 3a,5a-THP precursors are metabolized in the liver (Stanczyk, 2003).”
Double Dosing Levonorgestrel-Based Emergency Contraception for Individuals With Obesity
Edelman, A. B., Hennebold, J. D., Bond, K., Lim, J. Y., Cherala, G., Archer, D. F., & Jensen, J. T. (2022) · Obstetrics and Gynecology · doi:10.1097/aog.0000000000004717 · Cited by 19
Oral contraceptive use, iron stores and vascular endothelial function in healthy women
Friedman, J. C., Cremer, M., Jelani, Q., Huang, X., Jian, J., Shah, S. M., & Katz, S. D. (2011) · Contraception · doi:10.1016/j.contraception.2011.01.012 · Cited by 21
“Detrimental effects of synthetic progestins on endothelial function have been attributed to direct androgen receptor signaling effects in endothelial cells and indirect effects related to changes in lipid profile and/or levels of sex hormone binding globulin during therapy [1,20,21].”
Expression and Purification of Human Membrane Progestin Receptor α (mPRα)
Hossain, M. B., Oshima, T., Hirose, S., Wang, J., & Tokumoto, T. (2015) · PLoS ONE · doi:10.1371/journal.pone.0138739 · Cited by 18
“Natural progestin, progesterone identified in humans and certain animals (Stanczyk 2003), the chemical structure and biosynthesis pathway is shown in Fig.”
BackgroundNyberg, S. (2012) · Contraception · doi:10.1016/j.contraception.2012.09.024 · Cited by 17
“A receptor [37] (Fig.”
BackgroundComparison of the Impact of Four Generations of Progestins on Hemostatic Variables
Oslaković, S., & Zadro, R. (2012) · Clinical and Applied Thrombosis/Hemostasis · doi:10.1177/1076029612463426 · Cited by 17
Gargiulo-Monachelli, G. M., Meyer, M., Lara, A., Garay, L. I., Lima, A. E., Roig, P., Nicola, A. F. D., & Deniselle, M. C. G. (2019) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2019.105385 · Cited by 18
Dynamic change of estrogen and progesterone metabolites in human urine during pregnancy
Chen, J., Peng, Y., Luo, X., Zhu, Q., Lin, L.-Y., Yang, J., & Wang, P. (2025) · Scientific Reports · doi:10.1038/s41598-025-92866-0 · Cited by 16
Liang, J., Luo, Y., Li, B., Liu, S., Yang, L., Gao, P., Feng, L., Liu, Y., Du, Z., & Zhang, L. (2022) · Frontiers of Environmental Science & Engineering · doi:10.1007/s11783-022-1558-z · Cited by 16
Recent advances in structure of progestins and their binding to progesterone receptors
Cabeza, M., Heuze, Y., Sánchez, A., Garrido, M., & Bratoeff, E. (2014) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.3109/14756366.2014.895719 · Cited by 16
Schwartz, E., & Holtorf, K. (2011) · Clinics in Geriatric Medicine · doi:10.1016/j.cger.2011.07.013 · Cited by 16
Sampah, M. E., Laird, G. M., Blankson, J. N., Siliciano, R. F., & Coleman, J. S. (2015) · AIDS · doi:10.1097/qad.0000000000000681 · Cited by 15
“Not all progestogens are alike, and some bind different receptors, resulting in different biological effects [9,12].”
BackgroundMethodNomegestrol acetate-17b-estradiol for oral contraception
Burke, A. E. (2013) · Patient Preference and Adherence · doi:10.2147/ppa.s39371 · Cited by 15
“38 The large efficacy trials 28,29 included assessments of acne, and reached similar conclusions.”
Oral contraceptive progestins and angiotensin-dependent control of the renal circulation in humans
Sarna, M. A., Hollenberg, N. K., Seely, E. W., & Ahmed, S. B. (2009) · Journal of Human Hypertension · doi:10.1038/jhh.2008.148 · Cited by 15
Houshdaran, S., Chen, J. C., Vallvé-Juanico, J., Balayan, S., Vo, K. C., Smith‐McCune, K., Greenblatt, R. M., Irwin, J. C., & Giudice, L. C. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21072625 · Cited by 14
“The effects observed herein likely derive from the unique structures of progestins with their additional chemical groups and conformations (Figure 1), that confer different binding affinities for cognate nuclear receptors [1].”
BackgroundInfluentialMitchell, V. E., & Welling, L. L. M. (2020) · Adaptive Human Behavior and Physiology · doi:10.1007/s40750-020-00137-1 · Cited by 15
“Biological characteristics of synthetic progestins A fully comprehensive review of how chemical structures of progestins differ from endogenous progesterone is beyond the scope of this article (for review, see Schindler et al. 2008; Stanczyk 2003).”
BackgroundInfluentialAbnormal Bleeding during Menopause Hormone Therapy: Insights for Clinical Management
de Medeiros, S. F., Yamamoto, M. M. W., & Barbosa, J. S. (2013) · Clinical Medicine Insights Women s Health · doi:10.4137/cmwh.s10483 · Cited by 14
Hartman, J. K., Beames, T. G., Parks, B., Doheny, D. L., Song, G. K., Efremenko, A., Yoon, M., Foley, B. E., Deisenroth, C., McMullen, P. D., et al. (2018) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2018.05.016 · Cited by 14
“…(Caritis et al., 2011), norethindrone (LeBel et al., 1998; Griffith and Dai, 2004), cyproterone acetate (Kuhnz et al., 1993; Kuhnz et al., 1997), norgestrel (Stanczyk, 2003), mifepristone (Kekkonen et al., 1996; Heikinheimo, 1997; Sarkar, 2002), spironolactone (Abshagen et al., 1979) in humans.”
Jyoti, M. M. S., Rana, M. R., Ali, M. H., & Tokumoto, T. (2022) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2022.01.002 · Cited by 14
Progestogen use in women approaching the menopause and breast cancer risk
Campagnoli, C., Ambroggio, S., Lotano, M. R., & Peris, C. (2009) · Maturitas · doi:10.1016/j.maturitas.2008.10.017 · Cited by 13
Lyytinen, H. K., Dyba, T. A., Pukkala, ., & Ylikorkala, O. (2009) · International Journal of Cancer · doi:10.1002/ijc.24996 · Cited by 13
Kasserra, C., Li, J., March, B., & O'Mara, E. M. (2011) · Clinical Therapeutics · doi:10.1016/j.clinthera.2011.08.012 · Cited by 13
Rehm, K., Hankele, A., Ulbrich, S. E., & Bigler, L. (2021) · Talanta · doi:10.1016/j.talanta.2021.122358 · Cited by 12
“First steps of the reductive biosynthetic pathway of progesterone into its metabolites (based on source [10,12,14] and [13]).”
BackgroundA Review of Transdermal Hormonal Contraception
Graziottin, A. (2006) · Treatments in Endocrinology · doi:10.2165/00024677-200605060-00004 · Cited by 12
Clinical significance of reproductive hormones
Manocha, A., Kankra, M., Singla, P., Sharma, A. K., Ahirwar, A. K., & Bhargava, S. (2018) · Current Medicine Research and Practice · doi:10.1016/j.cmrp.2018.05.006 · Cited by 12
The Impact of Hormonal Contraceptives on Breast Cancer Pathology
Dorchak, J., Maria, S., Guarinoni, J. L., Duensing, A. U., Somiari, S., Cavanaugh, J. E., Deyarmin, B., Hu, H., Iida, J., Shriver, C. D., et al. (2018) · Hormones and Cancer · doi:10.1007/s12672-018-0332-y · Cited by 11
Nestorone (segesterone acetate) effects on neuroregeneration
Sitruk-Ware, R. L., Sussman, H., Brinton, R. D., Schumacher, M., Singer, P., Kumar, N., Nicola, A. F. D., El‐Etr, M., Guennoun, R., & Borlongan, C. V. (2024) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2024.101136 · Cited by 10
The Role of Progestogens in Menopausal Hormone Therapy
LIU, J. H. (2021) · Clinical Obstetrics & Gynecology · doi:10.1097/grf.0000000000000657 · Cited by 10
Structure-Activity Relationships
Lakshmanan, M. (2019) · Introduction to Basics of Pharmacology and Toxicology · doi:10.1007/978-981-32-9779-1_13 · Cited by 10
Novick, A. M., Duffy, K. A., Johnson, R. L., Sammel, M. D., Cao, W., Strasser, A. A., Sofuoglu, M., Kuzma, A., Loughead, J., Morrow, A. L., et al. (2022) · Biology of Sex Differences · doi:10.1186/s13293-022-00472-w · Cited by 9
“In addition, it will be important to determine differences between PROG and various progestins used for contraception on smoking-related measures as the latter are not metabolized into allopregnanolone [69, 70].”
BackgroundZubiaur, P., Ochoa, D., Gálvez, M. Á., Saiz‐Rodríguez, M., Román, M. C., Aguilar, M., de Pablo, I., Koller, D., & Abad‐Santos, F. (2019) · Advances in Therapy · doi:10.1007/s12325-019-01075-5 · Cited by 9
Romero, R. J., Meyyazhagan, A., Hassan, S. S., Creasy, G. W., & Conde‐Agudelo, A. (2024) · Clinical Obstetrics & Gynecology · doi:10.1097/grf.0000000000000867 · Cited by 13
Purification of the goldfish membrane progestin receptor α (mPRα) expressedin yeast Pichia pastoris
Oshima, T., NAKAYAMA, R., Roy, S. R., & Tokumoto, T. (2014) · Biomedical Research · doi:10.2220/biomedres.35.47 · Cited by 9
Stanczyk, F. Z. (2007) · Elsevier eBooks · doi:10.1016/b978-012369443-0/50067-3 · Cited by 9
TGR5 agonists induce peripheral and central hypersensitivity to bladder distension
Caldwell, A., Grundy, L., Harrington, A. M., Garcia‐Caraballo, S., Castro, J., Bunnett, N. W., & Brierley, S. M. (2022) · Scientific Reports · doi:10.1038/s41598-022-14195-w · Cited by 8
Effects of different progestogens on human breast tumor cell growth
Chen, F.-P., Chien, M., Chen, H.-Y., & Ng, Y. T. (2011) · Climacteric · doi:10.3109/13697137.2010.548565 · Cited by 8
Hormonal contraceptive use in HIV-infected women using antiretroviral therapy: a systematic review
Womack, J. A., Novick, G., & Goulet, J. L. (2015) · Open Access Journal of Contraception · doi:10.2147/oajc.s55038 · Cited by 8
Barbosa, C. P., Toniollo, G. H., & Guimarães, E. C. (2013) · Ciência Animal Brasileira · doi:10.5216/cab.v14i1.12588 · Cited by 8
Shifren, J. L., Rifai, N., Desindes, S., Mcllwain, M., Doros, G. D., & Mazer, N. A. (2008) · Obstetrical & Gynecological Survey · doi:10.1097/01.ogx.0000327780.22646.34 · Cited by 8
Casto, K. V., Arthur, L. C., Lynch-Wells, S., & Blake, K. R. (2023) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2023.106367 · Cited by 8
“For example, some progestins used in common HC formulas are androgenic, meaning that they facilitate the action of androgen binding or action, whereas others are anti-androgenic, meaning that they inhibit the action of androgen binding or action (Darney, 1995; Stanczyk, 2003).”
Progestin potency – Assessment and relevance to choice of oral contraceptives
Goldstuck, N. D. (2011) · Middle East Fertility Society Journal · doi:10.1016/j.mefs.2011.08.006 · Cited by 7
Soontrapa, N., Rattanachaiyanont, M., Warnnissorn, M., Wongwananuruk, T., Indhavivadhana, S., Tanmahasamut, P., Techatraisak, K., & Angsuwathana, S. (2022) · Scientific Reports · doi:10.1038/s41598-022-05578-0 · Cited by 6
Effects of Female Reproductive Hormones on Sports Performance
Lebrun, C. M., Joyce, S., & Constantini, N. (2020) · Contemporary Endocrinology · doi:10.1007/978-3-030-33376-8_16 · Cited by 7
Progestins and antiprogestins: mechanisms of action, neuroprotection and myelination
Schumacher, M., Ghoumari, A. M., Guennoun, R., Labombarda, F., González, S. L., Deniselle, M. C. G., Massaad, C., Grenier, J., Rajkowski, K. M., Robert, F., et al. (2005) · Springer eBooks · doi:10.1007/3-540-26940-1_8 · Cited by 6
Gönüllü, Ü., & Şaki, D. (2018) · Tropical Journal of Pharmaceutical Research · doi:10.4314/tjpr.v16i12.1 · Cited by 5
“Norethisterone (NE) is a potent synthetic progestogen which is used for the treatment of dysfunctional bleeding by shifting the time of menstruation [1,2].”
BackgroundPanek, A., Wójcik, P., Świzdor, A., Szaleniec, M., & Janeczko, T. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms25010508 · Cited by 5
“Progesterone is rapidly and extensively metabolized in the human body, mainly in the liver, but also in the brain, skin, and various other extrahepatic tissues [7,8].”
BackgroundHovanessian‐Larsen, L., Taylor, D., Hawes, D., SPICER, D. V., Press, M. F., Wu, A. H., Pike, M. C., & Pearce, C. L. (2012) · Contraception · doi:10.1016/j.contraception.2011.12.015 · Cited by 5
“A 10-mg dose of MPA is generally considered as approximately equivalent to a 1-mg dose of NET [10], so the doses being considered in these OCs are roughly comparable to the doses of MPA in sequential and continuous-combined EPT.”
MethodProgestogens: effects on clinical and biochemical parameters in postmenopausal women
Archer, D. F. (2005) · Menopause The Journal of The North American Menopause Society · doi:10.1097/01.gme.0000177319.31629.52 · Cited by 5
The importance of pharmacokinetic studies in drug development
Archer, D. F. (2013) · Contraception · doi:10.1016/j.contraception.2013.04.004 · Cited by 5
Oropesa, A. L., Guimarães, L., Martins, A., Rodríguez, F. S., & Guilhermino, L. M. (2011) · Ecotoxicology · doi:10.1007/s10646-011-0824-9 · Cited by 4
RetractedProgestógenos: farmacologia e uso clínico
Vigo, F. M., Lubianca, J. N., & Corleta, H. V. E. (2011) · Cited by 4
Human versus non-human sex steroid use in hormone replacement therapies part 1: Preclinical data
Atwood, C., & Ekstein, S. F. (2018) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2018.10.003 · Cited by 4
A detailed review of pharmacokinetics/pharmacodynamics of progestogens in oral contraception
GASPARD, U. J., Chatel, G., Douxfils, J., & Stanczyk, F. Z. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1730768 · Cited by 3
Data-Driven Electrochemistry Reveals the Impact of Hydrophobicity on Aptamer Cross-Reactivity
Carroll, E., Pence, M. A., Winterholler, E., Sparks, T. D., & Minteer, S. D. (2026) · ACS Measurement Science Au · doi:10.1021/acsmeasuresciau.6c00040 · Cited by 3
“26 Progesterone expression fluctuates throughout the reproductive cycle, regulating ovulation, and is essential in supporting early pregnancy.”
Kaur, K. K. (2018) · Open Access Journal of Gynecology · doi:10.23880/oajg-16000151 · Cited by 2
Sex differences in kidney and lung status in an animal model of brain death
Vidal‐dos‐Santos, M., Armstrong, R., van Zyl, M., Ricardo‐da‐Silva, F. Y., da Anunciação, L. F., Ramos, M. M. D. A., Correia, C. D. J., Ottens, P. J., Moreira, L. F. P., Leuvenink, H. G. D., et al. (2025) · Clinics · doi:10.1016/j.clinsp.2025.100623 · Cited by 3
“Progesterone is strongly susceptible to enzymatic reduction and is rapidly transformed into subproducts that take part in the synthesis of other steroid hormones, 24 whereas estradiol is converted from testosterone and estrone much later in the pathway.”
Novick, A. M., Stoddard, J., Johnson, R. L., Duffy, K. A., Berkowitz, L. N., Costa, V. D., Sammel, M. D., & Epperson, C. N. (2023) · PLoS ONE · doi:10.1371/journal.pone.0279764 · Cited by 4
Hossain, M. F., Hossain, S., Jyoti, M. M. S., Omori, Y., & Tokumoto, T. (2024) · Fish Physiology and Biochemistry · doi:10.1007/s10695-024-01315-8 · Cited by 3
“Progesterone, together with the sex steroid estrogen, is crucial for controlling the menstrual cycle in humans (Stanczyk 2003).”
A Review of Recent Findings for Obstetricians about Combined Oral Contraceptive Pills
Aminimoghaddam, S. (2017) · Journal of Obstetrics Gynecology and Cancer Research · doi:10.5812/jogcr.11200 · Cited by 3
Medication Interactions with Contraceptives
Perry, R., Stone, R. H., & Haider, S. (2014) · Springer eBooks · doi:10.1007/978-1-4939-1233-9_20 · Cited by 2
Role of Progestins in Reproduction
Onyeso, G. I., David, J., Egwu, M., & Welcome, M. O. (2024) · IntechOpen eBooks · doi:10.5772/intechopen.1007931 · Cited by 2
Park, Y., Bae, N., Choo, S. P., Lee, I., Lee, J. H., Kim, Y. J., Cho, S., Choi, Y. S., & Shin, J. (2025) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2025.114540 · Cited by 2
Hormonal contraceptive use in relation to basal and reactive testosterone, DHEAS, and cortisol
Casto, K. V., Farah, S., Castro, A., Akinola, M., & Mehta, P. H. (2025) · Hormones and Behavior · doi:10.1016/j.yhbeh.2025.105806 · Cited by 2
Zhai, Y., Bedi, K., WU, R. T., Feng, Y., Green, M. E., Pearce, C. L., Pike, M. C., Fearon, E. R., & Cho, K. R. (2025) · Cancers · doi:10.3390/cancers17213456 · Cited by 2
“Importantly, as noted by Stanczyk over two decades ago, all progestins are not created equal [39].”
Recent patent trends in the field of progesterone receptor agonists and modulators
Schmees, N., & Weinmann, H. (2009) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543770903312946 · Cited by 2
“A very different structural class of molecules was discovered by Organon [73,74], based on the tetrahydro-1[H]-dibenzo[b,f ] pyrido[1,2-d][1,4]oxazepine scaffold.”
BackgroundCholestasis, Contraceptives, and Free Radicals
Fernández‐Martínez, E. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-804274-8.00018-7 · Cited by 2
A case of multifocal central serous chorioretinopathy from a progestin-only contraceptive device
Shen, E., Tsao, S. W., Kuppermann, B. D., & Lu, S. (2019) · New Frontiers in Ophthalmology · doi:10.15761/nfo.1000235 · Cited by 2
Yaraghi, M., Noorafrooz, M., Motezarre, M., & Mousavi, S. A. (2025) · Transplantation Proceedings · doi:10.1016/j.transproceed.2025.03.021 · Cited by 1
Andersen, M. B., Josefsen, M. E., Rasmussen, K. D., & Hansen, M. (2025) · International Journal of Sports Physiology and Performance · doi:10.1123/ijspp.2024-0536 · Cited by 1
Hinchliffe, E., & Heazell, A. E. P. (2025) · Steroids · doi:10.1016/j.steroids.2025.109724 · Cited by 1
Orief, Y. I., Darwish, E. A. E., Elsamra, M. A., & Ragab, D. H. A. (2013) · Middle East Fertility Society Journal · doi:10.1016/j.mefs.2013.06.003 · Cited by 1
How does oral contraception affect mood
Pluchino, N., Caruso, A., & Daino, D. (2012) · Cited by 1
Park, K. J., Broach, V. A., Dennis, S., Linkov, I., Stanczyk, F. Z., Patel, P., Jotwani, A. R., Pearce, C. L., Pike, M. C., & Kauff, N. D. (2022) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-22-0217 · Cited by 1
Advances in Sources, Content Determination, and Bioactivity of 20α-Hydroxyprogesterone
Li, L., Yan, S., Cheng, Y., Zhong, C., Chen, C., & Gao, X. (2025) · Endocrine Metabolic & Immune Disorders - Drug Targets · doi:10.2174/0118715303302957250117052100 · Cited by 1
(2018) · Journal of environmental chemical engineering · doi:10.1016/j.jece.2018.06.013 · Cited by 1
Hormonal Contraception and Mood
Rapkin, A. J., & Sonalkar, S. (2011) · Contraception · doi:10.1002/9781444342642.ch20 · Cited by 1
Africander, D. (2010) · SUNScholar (Stellenbosch University) · Cited by 1
Oral contraceptive androgenicity and cognitive performance among women
Alvarez, K., & Spiers, M. (2014) · doi:10.17918/etd-4454 · Cited by 1
Hormonal Contraception and Mood
Rapkin, A. J., & Sonalkar, S. (2011) · Wiley-Blackwell eBooks · doi:10.1002/9780387978598.ch20 · Cited by 1
Progesterone Receptor Isoforms : functional Selectivity and Pharmacological Targeting
Khan, J. A. (2011) · theses.fr (ABES) · doi:10.70675/d565fcfezaed8z42f4za43az5b89ba52f3ae · Cited by 1
Metadata
- Authors
- Stanczyk, F. Z.
- Affiliations
- University of Southern California (US)
- Corresponding author
- Stanczyk, Frank Z
- ORCID
- Stanczyk, Frank Z
- Venue
- Steroids
- Publisher
- Elsevier BV
- Published
- 2003-11
- Volume
- 68
- Issue
- 10-13
- Pages
- 879-890
- ISSN
- 0039-128X (ISSN-L)
- OpenAlex
- W2037043326
- Cited by
- 226
- References
- 37
- Citations by year
- 2026: 5 · 2025: 11 · 2024: 5 · 2023: 5 · 2022: 13 · 2021: 7 · 2020: 11 · 2019: 15 · 2018: 15 · 2017: 9 · 2016: 9 · 2015: 11 · 2014: 11 · 2013: 15 · 2012: 8
- FWCI
- 2.47
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Steroids (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Reproductive Health and Contraception
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Keywords
- progestins, progesterone derivatives, testosterone derivatives, pregnane derivatives, norethisterone, levonorgestrel, hepatic first-pass metabolism, prodrugs, structure-function relationship, androgenic activity, pharmacokinetics
- MeSH terms
- Animals, Female, Humans, Liver, Models, Chemical, Norethindrone, Pregnanes, Progestins, Structure-Activity Relationship, Time Factors, Levonorgestrel, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review